Peregrine Pharmaceuticals reported $703K in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US USD 15.61M 1.88M
Amgen AMGN:US USD 415M 47M
Biocryst Pharmaceuticals BCRX:US USD 24.78M 753K
Bristol Myers Squibb BMY:US USD 294M 5M
Immunogen IMGN:US USD 867K 211K
Intrexon XON:US USD 2.04M 27K
Karyopharm Therapeutics KPTI:US USD 6.11M 199K
Mannkind MNKD:US USD 5.28M 3.81M
Novartis NOVN:VX USD 215M 13M
Peregrine Pharmaceuticals PPHM:US USD 703K 185K
Repligen RGEN:US USD 329K 58K
Roche Holding ROG:VX 256M 90M